Health Imetelstat leads to durable red blood cell transfusion independence Posted on January 9, 2024 by miyuru For heavily transfused patients with lower-risk myelodysplastic syndromes (LR-MDS) who are not responding to or are ineligible for erythropoiesis-stimulating agents (ESAs), the competitive telomerase inhibitor imetelstat leads to durable red….